1-12 of 12
Maud Janvier
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dasatinib (Sprycel®) and Low Intensity Chemotherapy for First-Line Treatment in Patients with De Novo Philadelphia Positive ALL Aged 55 and Over: Final Results of the EWALL-Ph-01 Study

Philippe Rousselot, MD, PhD, Marie Magdeleine Coudé, Françoise Huguet, Marina Lafage, Thibaut Leguay, Celia Salanoubat, MD, Francis Witz, MD, Magda Alexis, MD, Maud Janvier, MD, Mathilde Hunault, MD, PhD, Philippe Agape, Christian Berthou, MD, Eric Jourdan, MD, José Fernandes, MD, Laurent Sutton, Anne Banos, Oumedaly Reman, MD, Bruno Lioure, MD, Jean-Michel Cayuela, PhD, Sandrine Hayette, Nicola Gokbuget, MD, Dieter Hoelzer, MD, Andre Delannoy, MD, Carlo Gambacorti-Passerini, MD, Renato Bassan, MD, Josep-Maria Ribera, MD, PhD, Sebastian Giebel, MD, Herve Dombret, Oliver G. Ottmann, MD
Journal: Blood
Blood (2012) 120 (21): 666.
https://doi.org/10.1182/blood.V120.21.666.666
Published: 2012
Journal Articles

Fractionated Doses of Gemtuzumab Ozogamicin (GO) Combined to Standard Chemotherapy (CT) Improve Event-Free and Overall Survival in Newly-Diagnosed De Novo AML Patients Aged 50–70 Years Old: A Prospective Randomized Phase 3 Trial From the Acute Leukemia French Association (ALFA)

Sylvie Castaigne, Cécile Pautas, Christine Terre, Emmanuel Raffoux, MD, PhD, Dominique Bordessoule, Jean-Noel Bastie, MD, PhD, Ollivier Legrand, Xavier Thomas, MD, PhD, Pascal Turlure, Oumedaly Reman, Thierry De Revel, Lauris Gastaud, Claude Gardin, MD, Laurent Sutton, Jean Pierre Marolleau, Stephane De Botton, Olivier Hermine, Isabelle Plantier, Maud Janvier, Brigitte Dupriez, Marc Simon, Noemie De Gunzburg, Stephanie Foucault-Haiat, Nathalie Contentin, Celine Berthon, Pierre Fenaux, MD, PhD, Estelle Henry, Philippe Rousselot, MD, PhD, Claude Preudhomme, Sylvie Chevret, Hervé Dombret
Journal: Blood
Blood (2011) 118 (21): 6.
https://doi.org/10.1182/blood.V118.21.6.6
Published: 2011
Journal Articles

Rituximab and Reduced Dose CHOP (R-mini-CHOP) for Patients Over 80 Years with Diffuse Large B-Cell Lymphoma (DLBCL) – Groupe d'Etude Des Lymphomes De l'Adulte (GELA) Study LNH03-7B

Frederic Peyrade, Fabrice Jardin, MD, PhD, Christian Gisselbrecht, Antoine Thyss, Jean François Emile, MD, Sylvie Castaigne, MD, Bertrand Coiffier, MD, PhD, Corinne Haioun, MD, Serge Bologna, Olivier Fitoussi, Gerard Lepeu, MD, Christophe Fruchart, Dominique Bordessoule, PhD, Michel Blanc, MD, Richard Delarue, Maud Janvier, MD, Bruno Salles, MD, Andre Bosly, MD, Herve Tilly
Journal: Blood
Blood (2010) 116 (21): 853.
https://doi.org/10.1182/blood.V116.21.853.853
Published: 2010
Journal Articles

Dasatinib (Sprycel®) and Low Intensity Chemotherapy for First-Line Treatment In Elderly Patients with De Novo Philadelphia Positive ALL (EWALL-PH-01): Kinetic of Response, Resistance and Prognostic Significance

Philippe Rousselot, MD, PhD, Jean Michel Cayuela, MD, PhD, Sandrine Hayette, MD, PhD, Christian Récher, MD, PhD, Thibaut Leguay, MD, Celia Salanoubat, MD, Francis Witz, MD, Magda Alexis, MD, Mathilde Hunault, MD, PhD, Maud Janvier, MD, Philippe Agape, MD, Christian Berthou, MD, PhD, Eric Jourdan, MD, José Fernandes, MD, Laurent Sutton, MD, Anne Banos, MD, Oumedaly Reman, MD, Bruno Lioure, MD, Xavier Thomas, MD, PhD, Norbert Ifrah, MD, Nicola Gokbuget, MD, Dieter Hoelzer, MD, Andre Delannoy, MD, Renato Bassan, MD, Jose M. Ribera, MD, PhD, Sebastian Giebel, MD, PhD, Herve Dombret, MD, Oliver G. Ottmann, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 172.
https://doi.org/10.1182/blood.V116.21.172.172
Published: 2010
Journal Articles

Pharmacokinetics of Dasatinib as a First Line Therapy In Newly Diagnosed CML Patients (OPTIM dasatinib trial): Correlation with Safety and Response.

Philippe Rousselot, MD, PhD, Stéphane Boucher, MD, PhD, Gabriel Etienne, MD, PhD, Franck E Nicolini, MD, PhD, Emmanuelle Chauzit, MD, Pascale Cony Makhoul, MD, Valérie Coiteux, MD, Agnès Guerci, MD, Martine Gardembas, MD, Laurence Legros, MD, Lydia Roy, MD, Caroline Dartigeas, MD, Maud Janvier, MD, Christian Berthou, MD, Lambert Busque, MD, FRCPC, Mathieu Molimard, MD, PhD, Joelle Guilhot, PhD, Luigina Mollica, MD, FRCPC, PhD, Francois-Xavier Mahon, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3432.
https://doi.org/10.1182/blood.V116.21.3432.3432
Published: 2010
Journal Articles

A Prospective Randomized Study Comparing Dose Intensive Immunochemotherapy with R-ACVBP vs Standard R-CHOP In Younger Patients with Diffuse Large B-Cell Lymphoma (DLBCL). Groupe d'Etude Des Lymphomes De l'Adulte (GELA) Study LNH03-2B

Christian Recher, MD, PhD, Bertrand Coiffier, MD, PhD, Corinne Haioun, MD, Christophe Fermé, MD, Thierry Jo Molina, MD, Olivier Casasnovas, MD, Christian Gisselbrecht, MD, Andre Bosly, MD, Guy Laurent, MD, Franck Morschhauser, MD, PhD, Herve Ghesquieres, MD, Fabrice Jardin, MD, PhD, Serge Bologna, MD, Christophe Fruchart, MD, Danielle Canioni, MD, Bernadette Corront, MD, Jean Gabarre, MD, Christophe Bonnet, MD, Maud Janvier, MD, Herve Tilly, MD
Journal: Blood
Blood (2010) 116 (21): 109.
https://doi.org/10.1182/blood.V116.21.109.109
Published: 2010
Journal Articles

Dasatinib (Sprycel®) and Chemotherapy for First-Line Treatment in Elderly Patients with De Novo Philadelphia Positive ALL: Results of the First 22 Patients Included in the EWALL-Ph-01 Trial (on Behalf of the European Working Group on Adult ALL (EWALL))

Philippe Rousselot, Jean-Michel Cayuela, Christian Recher, Thibaut Leguay, Célia Salanoubat, Francis Witz, Magda Alexis, Maud Janvier, Mathilde Hunault, Philippe Agape, Christian Berthou, Eric Jourdan, José Fernandes, Laurent Sutton, Anne Banos, Oumedaly Reman, Bruno Lioure, MD, Nicola Gökbuget, Dieter Hoelzer, MD, PhD, André Delannoy, Renato Bassan, Jose-Maria Ribera, Sebastian Giebel, Sandrine Hayette, Oliver Ottmann, Hervé Dombret
Journal: Blood
Blood (2008) 112 (11): 2920.
https://doi.org/10.1182/blood.V112.11.2920.2920
Published: 2008
Journal Articles

Randomized Comparison of Standard Induction with Daunorubicin (DNR) for 3 Days vs Idarubicin (IDA) for 3 or 4 Days in AML pts Aged 50 to 70 and of Maintenance with Interleukin 2. Final Analysis of the ALFA 9801 Study.

Cecile Pautas, Xavier Thomas, Fatiha Merabet, Emmanuel Raffoux, Jean Henri Bourhis, Stephane de Botton, Oumedaly Reman, Pascal Turlure, Claude Gardin, Nathalie Contentin, Thierry de Revel, Isabelle Plantier, Philippe Rousselot, Claude Preudhomme, Pierre Fenaux, Maud Janvier, Christine Terre, Herve Dombret, Mauricette Michallet, Sylvie Chevret, Sylvie Castaigne
Journal: Blood
Blood (2007) 110 (11): 162.
https://doi.org/10.1182/blood.V110.11.162.162
Published: 2007
Journal Articles

Dexamethasone+Thalidomide (Dex/Thal) Compared to VAD as a Pre-Transplant Treatment in Newly Diagnosed Multiple Myeloma (MM): A Randomized Trial.

Margaret Macro, MD, Marine Divine, M.D., Yurdagul Uzunhan, M.D., Arnaud Jaccard, M.D., Didier Bouscary, M.D., Veronique Leblond, M.D., Maud Janvier, M.D., Philippe Genet, M.D., Sylvie Castaigne, M.D., Bruno Royer, M.D., Christian Allard, M.D., Sylvie Chevret, M.D., Jean-Paul Fermand, M.D.
Journal: Blood
Blood (2006) 108 (11): 57.
https://doi.org/10.1182/blood.V108.11.57.57
Published: 2006
Journal Articles

Intensive Chemotherapy Followed by Hematopoietic Stem Cell Rescue for Refractory or Recurrent Primary Central Nervous System (PCNSL) or Intra Ocular Lymphoma (IOL). Results of a Multicentric Phase II Study.

Carole Soussain, MD, Khe Hoang-Xuan, MD, Luc Taillandier, MD, Olivier Casasnovas, MD, Brigitte Dupriez, MD, Anne-Laure Taksin, MD, Bertrand Souleau, MD, Brigitte Kolb, MD, Arnaud Jaccard, MD, Jean-Marc Zini, MD, Sylvain Choquet, MD, Francis Witz, MD, Maud Janvier, MD, Veronique Leblond, MD
Journal: Blood
Blood (2006) 108 (11): 402.
https://doi.org/10.1182/blood.V108.11.402.402
Published: 2006
Journal Articles

Impact of Post-Remission Therapy on Survival of Older Patients with AML Treated with Intensive Chemotherapy: Results of the Multicenter ALFA-9803 Trial.

Pascal Turlure, Claude Gardin, Jean-Valere Malfuson, Xavier Thomas, Christine Terre, Nathalie Contentin, Emmanuel Raffoux, Stephane de Botton, Cecile Pautas, Oumedaly Reman, Jean-Henri Bourhis, Nathalie Dhedin, Maud Janvier, Pierre Fenaux, Sylvie Castaigne, Mauricette Michallet, Claude Preudhomme, Thierry de Revel, Dominique Bordessoule, Herve Dombret
Journal: Blood
Blood (2006) 108 (11): 421.
https://doi.org/10.1182/blood.V108.11.421.421
Published: 2006
Journal Articles

Randomized comparison of double induction and timed-sequential induction to a “3 + 7” induction in adults with AML: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 study

Clinical Trials & Observations
Sylvie Castaigne, Sylvie Chevret, Eric Archimbaud, Pierre Fenaux, Dominique Bordessoule, Hervé Tilly, Thierry de Revel, Marc Simon, Brigitte Dupriez, Michel Renoux, Maud Janvier, Jean-Michel Micléa, Xavier Thomas, Christian Bastard, Claude Preudhomme, Francis Bauters, Laurent Degos, Hervé Dombret
Journal: Blood
Blood (2004) 104 (8): 2467–2474.
https://doi.org/10.1182/blood-2003-10-3561
Published: 2004